This combination scenario is increasingly common in metabolic health practices as combination therapy regimens (basal insulin plus GLP-1 agonist) become a standard approach for Type 2 diabetes management
What to expect when you taper Because of how long GLP-1s stick around in the body, there are no symptoms due to the sudden stop of the medication, Alkhaddo says
Think of it as turning up the volume on your body's natural 'I'm full' signal
In the early 2020s, as GLP-1s became more popular, leading to shortages, doctors and patients began experimenting with stretching standard doses of Wegovy and Ozempic, which came in multidose injectable pens
These medications mimic the activity of natural hormone glucagon-like peptide-1 (GLP-1) receptors located in the pancreas, brain, and gut to slow gastric emptying, increase insulin secretion, reduce appetite, and improve blood glucose levels
Thank you for reading, listening and subscribing to Ground Truths